Sequent Scientific
Sequent Scientific Ltd., headquartered in India, is a prominent player in the pharmaceutical and biotechnology sectors. Founded in 2006, the company has established itself as a leader in the development and manufacturing of complex generics, particularly in the areas of injectable and oral dosage forms. With a strong operational presence across various regions, Sequent Scientific has achieved significant milestones, including multiple regulatory approvals from global health authorities. The company’s core offerings include a diverse range of pharmaceutical products, with a unique focus on high-quality, cost-effective solutions that cater to the evolving needs of healthcare providers. Sequent Scientific is recognised for its commitment to innovation and quality, positioning itself as a trusted partner in the global pharmaceutical landscape. Its notable achievements underscore its dedication to advancing healthcare through reliable and accessible medicines.
DitchCarbon Score
How does Sequent Scientific's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sequent Scientific's score of 19 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sequent Scientific's reported carbon emissions
In 2023, Sequent Scientific reported total carbon emissions of approximately 24,042,220 kg CO2e, comprising about 9,464,300 kg CO2e from Scope 1 and about 15,137,920 kg CO2e from Scope 2 emissions. This represents a significant increase from 2022, where the company recorded total emissions of approximately 23,676,650 kg CO2e, with Scope 1 emissions at about 7,125,210 kg CO2e and Scope 2 emissions at about 16,552,140 kg CO2e. Sequent Scientific has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of defined reduction strategies indicates a need for further commitment to climate action within the industry context. As the company continues to operate in a sector increasingly scrutinised for its environmental impact, establishing clear emissions reduction goals will be crucial for aligning with global climate objectives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 7,125,210 | 00,000,000 | 00,000,000 |
| Scope 2 | 16,552,140 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sequent Scientific is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
